Osteoarthritis (OA) and rheumatoid arthritis (RA) are the most well-known types of arthritis. Osteoarthritis is the most common type of the disease, affecting about 27 million Americans. Rheumatoid ...

Purpose: The pharmacology, pharmacokinetics, clinical efficacy, safety, and role of tocilizumab in rheumatoid arthritis (RA) are reviewed. Summary: Tocilizumab is a novel monoclonal antibody that ...

The European Commission has approved the first biosimilar version of Actemra/RoActemra, Roche’s $3 billion blockbuster, from German drugmaker Fresenius Kabi. The biosimilar of IL-6 inhibitor ...

20 February 2025 Hong Kong-based Ascletis Pharma announces today positive interim results from the first two cohorts of its randomized, double-blind, placebo-controlled Phase Ib multiple ascending ...

Nov. 13, 2024 — The use of biologic and targeted therapies for children with juvenile idiopathic arthritis (JIA) surpassed more typical therapies in recent years, according to ...

Bristol Myers Squibb today announced new five-year results from the POETYK PSO long-term extension (LTE) trial of Sotyktu (deucravacitinib) treatment in adult patients with moderate-to-severe plaque ...

Nausea, unpleasant taste, or headache may occur. If any of these effects last or get worse, tell your health care professional. Remember that this medication has been prescribed because your ...

Insufficient documentation in regard to fetal safety implies the discontinuation of leflunomide, tofacitinib as well as abatacept, rituximab, belimumab, tocilizumab, ustekinumab and anakinra before a ...

We recommend adjunctive therapy in selected patients with GCA (refractory or relapsing disease, presence of an increased risk for glucocorticoid-related adverse events or complications) using ...

Vaccines that are distributed in multidose vials can be administered once opened, until their expiration date, given proper storage and the scrupulous use of sterile technique. Recommendations for ...